Zdrowie i gospodarka · 20/08/2020

FDA Requests Public Comment on Proposed Collection of Information for Human Drug Compounding Outsourcing Facilities

The Food and Drug Administration is seeking public input on a proposed rule to collect information on human drug compounding outsourcing facilities under the Federal Food, Drug, and Cosmetic Act, with a 60-day comment period.